These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36835564)

  • 1. Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer.
    Lourenço T; Vale N
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
    Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
    Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.
    Kirtonia A; Gala K; Fernandes SG; Pandya G; Pandey AK; Sethi G; Khattar E; Garg M
    Semin Cancer Biol; 2021 Jan; 68():258-278. PubMed ID: 32380233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repositioning for prostate cancer: using a data-driven approach to gain new insights.
    Wang Q; Xu R
    AMIA Annu Symp Proc; 2017; 2017():1724-1733. PubMed ID: 29854243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing.
    Bahmad HF; Demus T; Moubarak MM; Daher D; Alvarez Moreno JC; Polit F; Lopez O; Merhe A; Abou-Kheir W; Nieder AM; Poppiti R; Omarzai Y
    Med Sci (Basel); 2022 Feb; 10(1):. PubMed ID: 35225948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential effectiveness and adverse implications of repurposing doxycycline in COVID-19 treatment.
    Narendrakumar L; Joseph I; Thomas S
    Expert Rev Anti Infect Ther; 2021 Aug; 19(8):1001-1008. PubMed ID: 33322952
    [No Abstract]   [Full Text] [Related]  

  • 8. Repurposing Alone and in Combination of the Antiviral Saquinavir with 5-Fluorouracil in Prostate and Lung Cancer Cells.
    Pereira M; Vale N
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline-a review.
    Siddiqui S; Deshmukh AJ; Mudaliar P; Nalawade AJ; Iyer D; Aich J
    J Egypt Natl Canc Inst; 2022 Aug; 34(1):33. PubMed ID: 35934727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of repurposed antiviral drugs: Lessons from COVID-19.
    Martinez MA
    Drug Discov Today; 2022 Jul; 27(7):1954-1960. PubMed ID: 35192924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Pharmacotherapy: Drug Development, Repurposing of Drugs, and the Role of Pharmacogenomics.
    Bock R; Babayeva M; Loewy ZG
    Methods Mol Biol; 2022; 2547():187-199. PubMed ID: 36068465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing.
    Bernal L; Pinzi L; Rastelli G
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Repurposing for Retinoblastoma: Recent Advances.
    Dandu K; Kallamadi PR; Thakur SS; Rao CM
    Curr Top Med Chem; 2019; 19(17):1535-1544. PubMed ID: 30659544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Repositioning of the α
    Florent R; Poulain L; N'Diaye M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer.
    Bibby BAS; Thiruthaneeswaran N; Yang L; Pereira RR; More E; McArt DG; O'Reilly P; Bristow RG; Williams KJ; Choudhury A; West CML
    BMC Urol; 2021 Jul; 21(1):96. PubMed ID: 34210300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning.
    Turanli B; Zhang C; Kim W; Benfeitas R; Uhlen M; Arga KY; Mardinoglu A
    EBioMedicine; 2019 Apr; 42():386-396. PubMed ID: 30905848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer.
    Stettner M; Krämer G; Strauss A; Kvitkina T; Ohle S; Kieseier BC; Thelen P
    Eur J Cancer Prev; 2012 Jan; 21(1):55-64. PubMed ID: 21979296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repurposing for the treatment of staphylococcal infections.
    Thangamani S; Mohammad H; Younis W; Seleem MN
    Curr Pharm Des; 2015; 21(16):2089-100. PubMed ID: 25760334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repurposing for bacterial infections.
    Ilyas M; Latif MS; Gul A; Babar MM; Rajadas J
    Prog Mol Biol Transl Sci; 2024; 207():1-21. PubMed ID: 38942533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates.
    De Lellis L; Veschi S; Tinari N; Mokini Z; Carradori S; Brocco D; Florio R; Grassadonia A; Cama A
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.